Showing results 1 to 4 of 4
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Chaperone protein P4HB predicts temozolomide response and prognosis in malignant glioma Journal:Oncology Letters | 2022 | ||
Diagnostic application of circulating CDH17 biomarker for screening GI malignancies (Poster Presentation) Proceeding/Conference:The 2023 American Society of Clinical Oncology Annual Meeting (02/06/2023-06/06/2023, Chicago) | 1-Jun-2023 | ||
Hyperoxia resensitizes chemoresistant glioblastoma cells to temozolomide through unfolded protein response Journal:Anticancer Research | 2014 | ||
Tissue cadherin 17 (CDH17): A favorable prognostic determinant of colorectal cancer using digital image analysis (Poster Presentation) Proceeding/Conference:The 2023 American Society of Clinical Oncology Annual Meeting (02/06/2023-06/06/2023, Chicago) | 1-Jun-2023 |